An oral hypoglycemic drug, C4H11N5, usually used in its hydrochloride form, that decreases glucose production by the liver and increases peripheral glucose uptake, used to treat type 2 diabetes.
M2 PHARMA-May 30, 2019-Anji Pharmaceuticals closes acquisition of Metformin DR and plans Phase 3 study in type 2 diabetes patients with chronic kidney disease
Global Banking News-May 30, 2019-Anji Pharmaceuticals closes acquisition of Metformin DR and plans Phase 3 study in type 2 diabetes patients with chronic kidney disease
M2 EQUITYBITES-May 30, 2019-Anji Pharmaceuticals closes acquisition of Metformin DR and plans Phase 3 study in type 2 diabetes patients with chronic kidney disease
Summary: Washington DC [USA], Apr 17 (ANI): A new study claims that 'metformin', a commonly used diabetes drug, has the potential to reduce the risk of heart diseases in non-diabetic patients.
One such pharmacologic maneuver that gained popularity lately is add-on use of metformin, a biguanide oral hypoglycemic agent, which is also used in polycystic ovary disease.
16, 2018 (HealthDay News) -- In adults with moderate obesity and either impaired glucose tolerance (IGT) or recently diagnosed mild type 2 diabetes (T2D), gastric banding and metformin are similarly effective for slowing disease progression over a two-year period, according to a study published online Oct.
Many years on metformin linked to anemia risk !-- -- People with type 2 diabetes who take metformin for many years are more likely to develop anemia than are those who do not, according to the results of a large analysis of data from an observational, population-based study with 20 years of follow-up.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.